Xu Kai-lin, Pan Xiu-ying, Yang Yu-juan, Lu Qun-xian, Li Zhen-yu, He Xu-peng
Department of Hematology, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China.
Zhonghua Xue Ye Xue Za Zhi. 2005 Nov;26(11):678-81.
To explore the killing effect of the mutant herpes simplex virus thymidine kinase (HSV-sr39tk) and its wild-type (HSV-tk) mediated by lentiviral vector on T lymphocytes in vitro and compare T cell survival rate after GCV or ACV treatment.
The three-plasmid lentiviral vector system including packaging plasmid DeltaNRF, envelope plasmid VSV-G and vector plasmid (pTK151 + HSV-sr39tk or pTK151 + HSV-tk) were cotransfected into human embryonic kidney 293T cells using modified calcium phosphate precipitation methods. The packaged virus was harvested 72 h later. The survival of T cells expressing HSV-sr39tk or HSV-tk was measured by MTT assay after 4 day-culture against a gradient of GCV or ACV concentrations.
The three plasmids were effectively cotransfected and a high titre of lentivirus was obtained (2 x 10(6) IU/ml). 39tk(+) T cell survival rates declined promptly when the prodrug GCV/ACV concentrations increased from 0 micromol/L to 10 micromol/L. The T cell survival rates in GCV group declined from (96.04 +/- 3.23)% to (36.76 +/- 4.38)% while in ACV group from (97.31 +/- 4.61)% to (43.75 +/- 8.99)%. However, when GCV/ACV concentrations were more than 10 micromol/L, further decline of 39tk(+) T cell survival rates became unobvious. The growth rate of 39tk(+) T cell exposed to GCV or ACV was obviously lower than that in un-transfected T cells (P < 0.05). Tk(+) T cells were sensitive to GCV (P < 0.05), but not to ACV (P > 0.05). There was a significant difference in killing effects between 39tk(+) T cell + GCV group and tk(+) T cell + GCV group (P < 0.05).
The lentiviral vectors containing HSV-sr39tk gene could infect T lymphocytes effectively and stably without affecting the proliferation of the transduced cell. In contrast to HSV-tk gene, T cells infected HSV-sr39tk were more sensitive not only to GCV but also to ACV.
探讨慢病毒载体介导的突变型单纯疱疹病毒胸苷激酶(HSV-sr39tk)及其野生型(HSV-tk)对T淋巴细胞的体外杀伤作用,并比较经更昔洛韦(GCV)或阿昔洛韦(ACV)处理后的T细胞存活率。
采用改良的磷酸钙沉淀法将包括包装质粒DeltaNRF、包膜质粒VSV-G和载体质粒(pTK151 + HSV-sr39tk或pTK151 + HSV-tk)的三质粒慢病毒载体系统共转染入人胚肾293T细胞。72小时后收获包装好的病毒。在针对不同梯度的GCV或ACV浓度进行4天培养后,通过MTT法检测表达HSV-sr39tk或HSV-tk的T细胞的存活率。
三种质粒有效共转染,获得了高滴度的慢病毒(2×10⁶ IU/ml)。当前体药物GCV/ACV浓度从0 μmol/L增加到10 μmol/L时,39tk(+) T细胞存活率迅速下降。GCV组T细胞存活率从(96.04±3.23)%降至(36.76±4.38)%,而ACV组从(97.31±4.61)%降至(43.75±8.99)%。然而,当GCV/ACV浓度超过10 μmol/L时,39tk(+) T细胞存活率的进一步下降变得不明显。暴露于GCV或ACV的39tk(+) T细胞的生长速率明显低于未转染的T细胞(P<0.05)。Tk(+) T细胞对GCV敏感(P<0.05),但对ACV不敏感(P>0.05)。39tk(+) T细胞+GCV组与tk(+) T细胞+GCV组的杀伤效果存在显著差异(P<0.05)。
含HSV-sr39tk基因的慢病毒载体可有效、稳定地感染T淋巴细胞,且不影响转导细胞的增殖。与HSV-tk基因相比,感染HSV-sr39tk的T细胞不仅对GCV更敏感,对ACV也更敏感。